JP2013535428A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535428A5
JP2013535428A5 JP2013518819A JP2013518819A JP2013535428A5 JP 2013535428 A5 JP2013535428 A5 JP 2013535428A5 JP 2013518819 A JP2013518819 A JP 2013518819A JP 2013518819 A JP2013518819 A JP 2013518819A JP 2013535428 A5 JP2013535428 A5 JP 2013535428A5
Authority
JP
Japan
Prior art keywords
rsv
polypeptide
composition
polypeptide epitope
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013518819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535428A (ja
JP5890407B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/043136 external-priority patent/WO2012006395A1/en
Publication of JP2013535428A publication Critical patent/JP2013535428A/ja
Publication of JP2013535428A5 publication Critical patent/JP2013535428A5/ja
Application granted granted Critical
Publication of JP5890407B2 publication Critical patent/JP5890407B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013518819A 2010-07-07 2011-07-07 呼吸器合胞体ウイルス抗原組成物および方法 Active JP5890407B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36202910P 2010-07-07 2010-07-07
US61/362,029 2010-07-07
US201161485669P 2011-05-13 2011-05-13
US61/485,669 2011-05-13
PCT/US2011/043136 WO2012006395A1 (en) 2010-07-07 2011-07-07 Respiratory syncytial virus antigenic compositions and methods

Publications (3)

Publication Number Publication Date
JP2013535428A JP2013535428A (ja) 2013-09-12
JP2013535428A5 true JP2013535428A5 (enExample) 2014-08-07
JP5890407B2 JP5890407B2 (ja) 2016-03-22

Family

ID=45438747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518819A Active JP5890407B2 (ja) 2010-07-07 2011-07-07 呼吸器合胞体ウイルス抗原組成物および方法

Country Status (13)

Country Link
US (1) US9487593B2 (enExample)
EP (1) EP2590675B1 (enExample)
JP (1) JP5890407B2 (enExample)
CN (2) CN106008716B (enExample)
AU (1) AU2011276251B2 (enExample)
BR (1) BR112013000345B1 (enExample)
CA (1) CA2799934C (enExample)
DK (1) DK2590675T3 (enExample)
ES (1) ES2688993T3 (enExample)
IL (1) IL222723B (enExample)
MX (1) MX340796B (enExample)
RU (1) RU2609661C2 (enExample)
WO (1) WO2012006395A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9433671B2 (en) 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
WO2014019718A1 (en) 2012-08-01 2014-02-06 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
JP6553033B2 (ja) * 2013-08-13 2019-07-31 ノースウェスタン ユニバーシティ ペプチドコンジュゲート粒子
US9975066B2 (en) 2014-05-27 2018-05-22 Artificial Cell Technologies, Inc. Automated layer by layer construction of multilayer coated cores by TFF
US9630994B2 (en) 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
JP6934862B2 (ja) 2015-09-16 2021-09-15 アーティフィシャル セル テクノロジーズ インコーポレイテッド 抗マラリア組成物および方法
US20170230649A1 (en) * 2016-02-05 2017-08-10 Qualcomm Incorporated Calibration of hybrid auto focus (af) imaging systems
LT3606942T (lt) 2017-04-04 2025-10-10 Savaiminės sąrankos baltymų nanostruktūros, eksponuojančios paramiksoviruso ir (arba) pneumoviruso f baltymus ir jų naudojimas
WO2019075400A1 (en) * 2017-10-13 2019-04-18 Trellis Bioscience, Llc CONFORMATIONAL EPITOPES IN A CENTRAL PROTECTED REGION OF SYNCYTIAL RESPIRATORY VIRUS PROTEIN G
AU2019228551B2 (en) 2018-02-28 2025-07-24 University Of Washington Self-assembling nanostructure vaccines
JP2021534239A (ja) 2018-08-08 2021-12-09 トレリス・バイオサイエンス,エルエルシー Rsvの改善された受動的および能動的ワクチン
US20230414526A1 (en) * 2022-03-29 2023-12-28 Artificial Cell Technologies, Inc. Respiratory syncytial virus antigenic compositions and methods

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2167274C (en) * 1993-08-06 2007-11-27 Sonia E. Sanhueza Inactivated respiratory syncytial viral vaccines
FR2718452B1 (fr) 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
CA2198279A1 (en) 1994-08-25 1996-02-29 Johannes Petrus Maria Langedijk Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection
FR2726471B1 (fr) 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
AUPO026596A0 (en) 1996-06-05 1996-06-27 Biomolecular Research Institute Limited Viral peptide
ATE412666T1 (de) 2000-10-18 2008-11-15 Us Gov Health & Human Serv Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
FR2819810B1 (fr) 2001-01-23 2004-05-28 Pf Medicament Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
AUPR520201A0 (en) 2001-05-23 2001-06-14 Commonwealth Scientific And Industrial Research Organisation Antiviral compounds
JP3997930B2 (ja) 2003-02-27 2007-10-24 富士ゼロックス株式会社 カーボンナノチューブの製造装置および製造方法
US7368537B2 (en) 2003-07-15 2008-05-06 Id Biomedical Corporation Of Quebec Subunit vaccine against respiratory syncytial virus infection
US7348399B2 (en) * 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
WO2006023029A2 (en) * 2004-06-16 2006-03-02 The Johns Hopkins University The cysteine-rich region of respiratory syncytial virus and methods of use therefor
US20080131450A1 (en) 2004-07-23 2008-06-05 Pierre Fabre Medicament Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions
WO2006079928A2 (en) * 2005-01-31 2006-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Polyelectrolyte multilayer film, preparation and uses thereof
WO2006108226A1 (en) * 2005-04-12 2006-10-19 The University Of Queensland Vaccine delivery system
CN103357007A (zh) * 2005-10-25 2013-10-23 人工细胞技术公司 免疫原性组合物及其使用方法
EP1972348A1 (en) 2007-03-14 2008-09-24 Pierre Fabre Medicament Novel vaccine composition for the treatment of respiratory infectious diseases
US20100203071A1 (en) 2007-03-21 2010-08-12 Norman Blais Chimeric antigens
US7723294B2 (en) 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
WO2009079066A2 (en) * 2007-09-26 2009-06-25 Aparna Biosciences Therapeutic and vaccine polyelectrolyte nanoparticle compositions
EP2058002A1 (en) * 2007-10-31 2009-05-13 Bestewil Holding B.V. Reconstituted respiratory syncytial virus membranes and use as respiratory syncytial virus vaccine
KR20110045008A (ko) 2008-07-18 2011-05-03 아이디 바이오메디컬 코포레이션 오브 퀘벡 키메라 호흡기 세포융합 바이러스 폴리펩티드 항원
US20110318376A1 (en) 2008-12-24 2011-12-29 University Of Rochester Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
US8846056B2 (en) 2009-08-04 2014-09-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control Anti-RSV immunogens and methods of immunization
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods

Similar Documents

Publication Publication Date Title
JP2013535428A5 (enExample)
RU2013101972A (ru) Антигенные композиции респираторного синцитиального вируса и способы
JP2015530973A5 (enExample)
JP2013172734A5 (enExample)
JP2012126742A5 (enExample)
JP2017160222A5 (enExample)
JP2019513005A5 (enExample)
WO2008114149A3 (en) Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains
JP2018510132A5 (enExample)
JP2009540831A5 (enExample)
JP2012501959A5 (enExample)
JP2011526480A5 (enExample)
FI3430027T3 (fi) Peptidi käytettäväksi ei-pienisoluisen keuhkosyövän ja pienisoluisen keuhkosyövän hoidossa
JP2013506411A5 (enExample)
JP2016512213A5 (enExample)
RU2571204C3 (ru) Специфические связывающие агенты против в7-н1
JP2018029594A5 (enExample)
JP2015509097A5 (enExample)
JP2013529070A5 (enExample)
JP2015509085A5 (enExample)
JP2019516663A5 (enExample)
JP2013502918A5 (enExample)
JP2019530441A5 (enExample)
HK1200842A1 (en) Proteins with improved half-life and other properties
JP2013518057A5 (enExample)